Prostate Cancer - Results from #80

Exposure-response analyses of abiraterone and its metabolites in real-world patients with metastatic castration-resistant prostate cancer. October 24, 2019

High-level expression of protein tyrosine phosphatase non-receptor 12 is a strong and independent predictor of poor prognosis in prostate cancer. October 24, 2019

Assessment of Return to Baseline Urinary and Sexual Function Following Primary Focal Cryotherapy for Nonmetastatic Prostate Cancer. October 24, 2019

Towards precision oncology in advanced prostate cancer. October 24, 2019

MRI-Derived Radiomics to Guide Post-operative Management for High-Risk Prostate Cancer. October 24, 2019

Inflammation appears as high Prostate Imaging-Reporting and Data System scores on prostate magnetic resonance imaging (MRI) leading to false positive MRI fusion biopsy. October 24, 2019

Evaluation of the residual prostate cancer rate on cystoprostatectomy specimen in patients treated with radiotherapy for prostate cancer. October 23, 2019

Comparison of different lymph node staging schemes in prostate cancer patients with lymph node metastasis. October 23, 2019

68Ga-PSMA I&T PET/CT for primary staging of prostate cancer. October 23, 2019

Prognostic significance of castrate testosterone levels for patients with intermediate and high risk prostate cancer. October 23, 2019

Efficacy and safety of 177Lutetium-prostate-specific membrane antigen therapy in metastatic castration-resistant prostate cancer patients: First experience in West Asia - A prospective study. October 23, 2019

Short-term androgen deprivation therapy combined with radiotherapy as salvage treatment after radical prostatectomy for prostate cancer (GETUG-AFU 16): a 112-month follow-up of a phase 3, randomised trial. October 22, 2019

Comparison of outcome endpoints in intermediate- and high-risk prostate cancer after combined-modality radiotherapy. October 22, 2019

Current recommendations for prostate cancer genetic testing: NCCN prostate guideline. October 22, 2019

Advancing Age and the Odds of Upgrading and Upstaging at Radical Prostatectomy in Men with Gleason Score 6 Prostate Cancer. October 22, 2019

Accuracy of multiparametric magnetic resonance imaging for detecting extracapsular extension in prostate cancer: a systematic review and meta-analysis. October 22, 2019

Prospective multicentre study using high intensity focused ultrasound (HIFU) for the focal treatment of prostate cancer: Safety outcomes and complications. October 21, 2019

Outcomes of pathologically localized high-grade prostate cancer treated with radical prostatectomy. October 21, 2019

MRI-Fusion Targeted vs. Systematic Prostate Biopsy-How Does the Biopsy Technique Affect Gleason Grade Concordance and Upgrading After Radical Prostatectomy? October 21, 2019

Risk of Gleason Score 3 + 4 = 7 prostate cancer upgrading at radical prostatectomy is significantly reduced by target biopsy compared to standard biopsy technique. October 21, 2019

Page 5 of 1017

E-Newsletters

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.